Literature DB >> 1097546

New knowledge of chlamydiae and the diseases they cause.

J T Grayston, S Wang.   

Abstract

The trachoma and LGV organisms, the human pathogens of the species C. trachomatis, cause oculogenital infections and disease syndromes of the eye and genital tract. The incidence of the most prominent disease, endemic trachoma with eye-to-eye transmission, is decreasing all over the world. At the same time there is increasing recognition of high-frequency venereal infections with trachoma organisms and of the genital disease and occasional ocular disease that they cause. Laboratory techniques for diagnosis and investigation are improving, but work with these interesting intermediate agents remains more difficult than that with many other microorganisms. Proper recognition of the diseases is important because specific therapy is available.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097546     DOI: 10.1093/infdis/132.1.87

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  161 in total

1.  Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis.

Authors:  R S Stephens; F S Fawaz; K A Kennedy; K Koshiyama; B Nichols; C van Ooij; J N Engel
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.

Authors:  Peiyi Fan; Feng Dong; Yanqing Huang; Guangming Zhong
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  A murine model for the study of Chlamydia trachomatis genital infections during pregnancy.

Authors:  S Pal; E M Peterson; L M De La Maza
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

Review 5.  Chlamydial infections.

Authors:  J Schachter
Journal:  West J Med       Date:  1990-11

6.  Serovar distribution of urogenital C trachomatis isolates in Germany.

Authors:  H Näher; D Petzoldt
Journal:  Genitourin Med       Date:  1991-04

Review 7.  Chlamydia trachomatis and clinical genital infections: a general review.

Authors:  P Terho
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  Differences in outer membrane proteins of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis.

Authors:  B E Batteiger; W J Newhall; R B Jones
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  The use of cycloheximide-treated cells for isolating trachoma agents under field conditions.

Authors:  J Schachter; C R Dawson; I Hoshiwara; T Daghfous; J Banks
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

10.  Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B.

Authors:  A Villeneuve; L Brossay; G Paradis; J Hébert
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.